Lazard Asset Management
CDNA icon

Lazard Asset Management’s CareDx CDNA Stock Holding History

Lazard Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Sell
94,747
-22,004
-19% -$479K ﹤0.01% 842
2026
Q1 		$2.03M Buy
116,751
+449
+0.4% +$8.5K ﹤0.01% 884
2025
Q4 		$2.19M Sell
116,302
-10,033
-8% -$168K ﹤0.01% 828
2025
Q3 		$1.84M Buy
126,335
+23,595
+23% +$336K ﹤0.01% 887
2025
Q2 		$2.01M Buy
102,740
+88,909
+643% +$1.58M ﹤0.01% 1016
2025
Q1 		$245K Buy
13,831
+3,713
+37% +$80K ﹤0.01% 1576
2024
Q4 		$216K Sell
10,118
-22,540
-69% -$548K ﹤0.01% 1591
2024
Q3 		$1.02M Buy
+32,658
New +$813K ﹤0.01% 1068
2023
Q2 		– Sell
-2,033
Closed -$18K – 2326
2023
Q1 		$18K Buy
2,033
+581
+40% +$7.43K ﹤0.01% 2066
2022
Q4 		$16K Sell
1,452
-6,286
-81% -$93.2K ﹤0.01% 2159
2022
Q3 		$131K Buy
7,738
+2,448
+46% +$52.5K ﹤0.01% 1366
2022
Q2 		$113K Buy
5,290
+2,065
+64% +$57.3K ﹤0.01% 1465
2022
Q1 		$119K Buy
3,225
+782
+32% +$30.5K ﹤0.01% 1351
2021
Q4 		$111K Buy
2,443
+4
+0.2% +$209 ﹤0.01% 1406
2021
Q3 		$154K Sell
2,439
-160
-6% -$12.2K ﹤0.01% 1333
2021
Q2 		$237K Sell
2,599
-19
-0.7% -$1.51K ﹤0.01% 1195
2021
Q1 		$178K Sell
2,618
-431
-14% -$33.5K ﹤0.01% 1117
2020
Q4 		$220K Sell
3,049
-1,307
-30% -$75.7K ﹤0.01% 1089
2020
Q3 		$165K Sell
4,356
-819
-16% -$27.7K ﹤0.01% 980
2020
Q2 		$183K Sell
5,175
-2,599
-33% -$74K ﹤0.01% 929
2020
Q1 		$169K Buy
7,774
+4,406
+131% +$98.7K ﹤0.01% 923
2019
Q4 		$72K Buy
3,368
+1,975
+142% +$45.3K ﹤0.01% 996
2019
Q3 		$31K Buy
+1,393
New +$38.6K ﹤0.01% 1021

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management's CDNA Position: Q2 2026 in Review

Lazard Asset Management reduced its CareDx (CDNA) stake by 19% in Q2 2026, selling an estimated $479K and leaving 94,747 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #842.

Lazard Asset Management first reported a position in CDNA in Q3 2019 and has held it in 23 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Lazard Asset Management held 94,747 shares of CareDx worth $2.7M as of Q2 2026.
  • Lazard Asset Management sold 22,004 CareDx shares in Q2 2026, an estimated $479K.
  • CareDx made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #842 holding.
  • Lazard Asset Management first reported a position in CareDx in Q3 2019 and has held it in 23 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.